Goldman Sachs (GS.N) is in talks to buy a large group of company stakes being sold by asset manager Invesco as it looks to shift illiquid holdings whose value has been hit by the COVID-19 disease outbreak, Sky News reported citing sources.
The holdings are valued at several hundred million pounds, the report said here
A unit of Goldman Sachs Asset Management is close to buying the stakes, which include a holding in Oxford Nanopore, a gene sequencing specialist, according to the report.
Some of the collection of private company holdings were assembled by Neil Woodford, whose flagship fund was winded down last year following a four-and-a-half month suspension, that marked a stunning reversal of fortune for one of Britain’s most high profile investors.
Representatives at Goldman Sachs and Invesco declined to comment.
Source: Reuters
Can’t stop reading? Read more
Mark Cuban joins $750m Harbinger Sports Partners Fund targeting minority stakes in top US sports franchises
Mark Cuban joins $750m Harbinger Sports Partners Fund targeting minority stakes in top US sports...
KKR backs 544-bed student accommodation scheme near University of Warwick
KKR backs 544-bed student accommodation scheme near University of Warwick KKR has agreed to...
Montagu-backed Wireless Logic welcomes General Atlantic as investor in £3.5bn deal
Montagu-backed Wireless Logic welcomes General Atlantic as investor in £3.5bn deal Montagu has...